This, therefore, means that for public administration to fully and adequately complement the democratic imperative—for the ...

MAIA Biotechnology, Inc., ("MAIA", the "Company"), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced positive updated data from its THIO-101 ...

Keith Buettner; Vice President, IR and Financial Planning and Analysis; Xylem Inc. Matthew Pine; President, Chief Executive Officer, Director; Xylem Inc. William Gro ...

BioHarvest Sciences Inc.’s BHST share price has surged by 13.13%, which has investors questioning if this is right time to sell.

However, developers and advocates of decentralization are ramping up efforts to improve and expand networks; they also are seeking solutions to some of the technical challenges that popularity brings.